4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-23-036073
Director sold 7,100 shares at $18.03 ($127,987)
- Director acquired 8,289 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Schoeneck James A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-07 | Grant or award : show line 1 in the form 10b5-1 | +8,289 | 28,766 | D | ||
| 2023-06-07 | Sale : show line 2 in the form 10b5-1 | −7,100 | $18.03 | $127,987 | 73,722 | I |
| Open-market sales · 7,100 sh · avg $18.03 · $127,987 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-07 | Grant or award : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | +12,666 | 12,666 | D |
Loading xslF345X04/doc4.xml…